101
Views
34
CrossRef citations to date
0
Altmetric
Research Article

Arsenic Trioxide: Acute Promyelocytic Leukemia and Beyond

, &
Pages 1535-1540 | Published online: 01 Jul 2009

  • Correia, M.A. and Becker, C.E. (1989) "Chelators and heavy metal intoxication". In: Katzung, B.G., ed. Basic and Clinical Pharmacology (Prentice-Hall, London), p 747.
  • Finch, R.G. and Snyder, I.S. (1982) "Antiprotozoal drugs", In: Craig, C.R. and Stitzel, R.K., eds. Modern Pharmacology (Little, Brown, Boston), p 698.
  • Cutler, E.G. and Bradford, E.H. (1878) "Action of iron, cod-liver oil, and arsenic on the globular richness of the blood". American Journal of Medical Sciences 75, 74-84.
  • Forkner, C.E. and Scott, T.F.M. (1931) "Arsenic as a therapeutic agent in chronic myelogenous leukemia". Journal of the American Medical Association 97, 3-5.
  • Kandel, E.V. and LeRoy, G.V. (1937) "Chronic arsenical poisoning during the treatment of chronic myeloid leukemia", Archives of Internal Medicine 60, 846-866.
  • Waxman, S. and Anderson, K.C. (2001) "History of the development of arsenic derivatives in cancer therapy". The Oncologist 6(Suppl. 2), 3-10.
  • Warrell, J.P., de Thé, H., Wang, Z.Y. and Degos, L. (1993) "Acute promyelocytic leukemia". New England Journal of Medicine 329, 177-189.
  • Chen, G.Q., Shi, X.G., Tang, W., Xiong, S.M., Zhu, J., Cai, X., Han, Z.G., Ni, J.H., Shi, G.Y., Jia, P.M., Liu, M.M., He, K.L., Niu, C. Ma, J., Zhang, P., Zhang, T.D., Paul, P., Naoe, T., Kitamura, K., Miller, W., Waxman, S., Wang, Z.Y, de Thé, H., Chen, S.J. and Chen, Z. (1997) "Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): 1. As2O3 exerts, dose-dependent dual effects on APL cells". Blood 89, 3345-3353.
  • Wang, Z.G., Rivi, R., Delva, L., Konig, A., Scheinberg, D.A., Gambacort-Passerini, C., Gabrilove, J.L., Warrell, R.P. and Pandolfi, P.P. (1998) "Arsenic trioxide and melarsoprol induce programmed cell death in myeloid leukemia cell lines and function in a PML and PML-RARa independent manner". Blood 92, 1497-1504.
  • Soignet, S.L. (2001) "Clinical experience of arsenic trioxide in relapsed acute promyelocytic leukemia". The Oncologist 6(Suppl. 2), 11-16.
  • Soigriet, S., Fleischauer, A., Polyak T., Heller, G. and Warrell, R.P. (1997) "All-trans retinoic acid significantly increases 5-year survival in patients with acute promyeloeytic leukemia: long-term follow-up of the New York study". Cancer Chemotherapy and Pharmacology 40(Suppl.), S25-S29.
  • Sun, H.D., Ma, L., Hu, X.C. and Zhang, T.D. (1992) "Ai-Lin 1 treated 32 cases of acute promyelocyiic leukemia". Chinese Journal of Integrated Chinese and Western Medicine 12, 170-171.
  • Shen. Z. X., Chen, G.Q., Ni, JH., Li, X.S, Xiong, S.M., Qiu, Q.Y., Zhu, J., Tang, W., Sua, G.L., Yang, K.Q., Chen, Y. Zhou, L., Hang, Z.W., Wang, Y.T., Ma, J., Zhang, P., Zhang, T.D., Chen, S.J., Chen, Z. and Wang, Z.Y. (1997) "Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): II. Clinical efficacy and pharmacokinetics in relapsed patients". Blood 89, 3354-3360.
  • Niu, C., Yan, H., Yu, T., Sun, H.P., Liu, J.X., Li, X.S., Wu, W., Zhang, F.Q., Chen, Y., Zhou, L., Li, J.M., Zeng, X.Y., Yang, R.R., Yuan, M.M., Ren, M.Y., Gu, F.Y., Cao, Q., Gu, B.W., Su, X.Y., Chen, G.Q., Xiong, S.M., Zhang, T.D., Waxman, S., Wang, Z.Y., Chen, Z., Hu, J., Shen, Z.X. and Chen, S.J. (1999) "Studies on treatment of acute promyelocytic leukemia with arsenic trioxide: remission induction, follow up. and molecular monitoring in 11 newly diagnosed and 47 relapsed acute promyelucytic leukemia patients". Blood 94, 3315-3324.
  • Soignet, S.L., Maslak, P., Wang, Z.G., Jhanwar. S., Calleja, E., Dardashti, L.J., Corso, D., de Balsio, A., Gabrilove, J., Scheinberg, D.A., Pandolfi, P.P. and Warrell, R.P. (1998) "Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide". New England Journal of Medicine 339, 1341-1348.
  • Jun, M., Guoqiang, X. and Guang, Y. (2000) "Clinical observations of As2O3 safety in the treatment of pediatric patients with acute promyelocytic leukemia (APL)". Blood 96(Suppl. 1), 722a.
  • Zhu, J., Koken, H.M., Quignon, F., Chelbi-Alix, M.K., Degos, L., Wang, Z.V., Chen, Z. and de Thé. H. (1997) "Arsenic-induced PML targeting onto nuclear bodies: implications for the treatment of acute promyelocytic leukemia", Proceedings of the National Academy of Sciences 94, 3978-3983.
  • Shao, W., Fanclli, M., Ferrara, F.F., Riccioni, R., Rosenauer, A., Davison, K., Lamph, W.W., Waxman, S., Pelicci, P.G., Coco, F.L., Avvisati, G., Testa, U., Peschle, C., Gambacorti-Passerini C. Nervi, C. and Miller, W.H. (1998) "Arsenic trioxide as an inducer of apoptosis and loss of PML/RARa protein in acute promyelocytic leukemia cells". Journal of the National Cancer Institute 90, 124-133.
  • Li, Y.M. and Broome, J.D. (1999) "Arsenic targets tubulins to induce apoptosis in myeloid leukemia cells". Cancer Research 59, 776-780.
  • Roboz, G.J. Dias, S., Lam, G., Lane, W.J., Soignet, S.L., Warrell, Jr., R.P. and Rafti, S. (2000) "Arsenic trioxide induces dose- and time-dependent apoptosis of endothelium and may exert an antileuketnic effect via inhibition of angiogcnesis". Blood 96, 1525-1530.
  • Chen, G.Q., Zhu. J., Shi, X.G., Ni, J.H., Zhong, H.J., Si, G.Y., Jin, X.L., Tang, W., Li, X.S., Xong, S.M., Shen, Z.X., Sun, G.L., Ma, J., Zhang, P., Zhang, T.D., Gazin, C., Naoe, T., Chen, S.J., Wang, Z.Y. and Chen, Z. (1996) "In vitra studies on cellular and molecular mechanisms of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia: As2O3 induces NB4 cell apoptosis with downregulation of Bcl-2 expression and modulation of PML-RARa/PML proteins". Blood 88, 1052-1061.
  • Akao, Y., Mizoguchi, H., Kojima, S., Naoe, T., Ohishi, N. and Yagi, K. (1998) "Arsenic induces apoptosis in B-cell leukaemic cell lines in vitra: activation of caspases and down-regulation of Bcl-2 protein". British Journal of Haematology 102, 1055-1060.
  • Zhang, W., Ohnishi, K., Shigeno, K., Fujisama, S., Nailo, K., Nakamura, S., Takeshita, K., Takeshila, A. and Ohno, R. (1998) "The induction of apoptosis and cell cycle arrest by arsenic trioxide in lymphoid neoplasms", Leukemia 12, 1383-1391.
  • Jing, Y., Dai, J., Chalmers-Redman, R.M.E., Tatton, W.G. and Waxman, S. (1999) "Arsenic trioxide selectively induces acute promyelocytic leukemia cell apoptosis via a hydrogen peroxide-dependent pathway". Blood 94, 2102-2111.
  • Perkins, C., Kim, C.N., Fang, G. and Bhalla, K.N. (2000) "Arsenic induces apoptosis of multidrug-resistant human myeloid leukemia cells that express Bcr-Abl or overexpress MDR, MRP, Bcl-2, or BCL-xL" Blood 95, 1014-1022.
  • Bachleitner-Hofmann, T., Gisslinger, B., Grumbeck, F. and Gisslinger. H. (2001) "Arsenic trioxide and ascorbic acid: synergy with potential implications for the treatment of acute myeloid leukaemia?". British Journal of Haematology 112, 783-786.
  • Zheng, J., Deng, Y.P., Lin, C., Fu, M., Xiao, P.G. and Wu, M. (1999) "Arsenic trioxidc induces apoptosis of HPV16 DNA-immortalized human cervical epithelial cells and selectively inhibits viral gene expression". International Journal of Cancer 82, 286-292.
  • Ishitsuka, K., Hanada. S., Suzuki, S., Utsunomiya, A., Chyuman, Y., Takeuchi, S., Takeshita, T., Shimotakahara, S., Uozumi, K., Makino, T. and Arima, T. (1998) "Arsenic trioxide inhibits growth of human T-cell leukaemia virus type I infected T-cell lines more effectively than relinoic acids", British Journal of Haematology 103, 721-728.
  • Rousselot, P., Labaume, S., Marollcacu, J.P., Larghero, J., Noguera, M.H., Brouet, J.C. and Fermand, J.P. (1999) "Arsenic trioxide and melarsoprol induce apuptosis in plasma cell lines and in plasma cells from myeloma patients". Cancer Research 59, 1041-1048.
  • Wang, T.S., Kuo, C.F., Jan, K.Y. and Huang, H. (2001) "Arsenic induces apoptosis in Chinese hamster ovary cells by generation of reactive oxygen species". Journal of Cellular Physiology 169, 256-268.
  • Huang, X.J., Wieroik, P.H., Klein, R.S. and Gallagher, R.E. (1999) "Arsenic trioxide induces apoptosis of myeloid leukemia cells by activation of caspases", Medical Oncology 16, 58-64.
  • Dai, J., Weinberg, R.S., Waxman, S. and Jing, Y. (1999) "Malignant cells can be sensitized to undergo growth inhibition and apoptosis by arsenic trioxide through modulation of the gluiathione redox system". Blood 93, 268-277.
  • Grad, J.M., Bahlis, N.J., Reis, I., Oshiro, M.M., Dalton, W.S. and Boise, L.H. (2001) "Ascorbic acid enhances arsenic trioxide-induced cytotoxicity in multiple myeloma cells". Blood 98, 805-813.
  • Murgo, A.J. (2001) "Clinical trials of arsenic trioxide in hematologic and solid tumors: overview of the national cancer institute cooperative research and development studies". The Oncologist 6(Suppl. 2), 22-28.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.